Skip to content

Comparison decrease of the pain in transforaminal epidural steroid injections and pulsed radiofrequency in patients with low back pain

Comparison of the pain in transforaminal epidural steroid injections and pulsed radiofrequency in patients with low back pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201411037984N22
Enrollment
42
Registered
2015-04-06
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back pain. Low back pain

Interventions

Intervention 1: In the study group, Pulsed radiofrequency. Intervention 2: In the control group, Transforaminal epidural steroid injection.
Rehabilitation
Treatment - Drugs
In the study group, Pulsed radiofrequency
In the control group, Transforaminal epidural steroid injection

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Main inclusion criteria: Persistent low back pain with or without pain radiating to the upper leg; Age > 18 years old; ASA Class I- II; Lasek test =>50 degrees; Confirming the involvement of nerve roots , vertebral disc protrusion is based on clinical examination and CT scan and MRI findings; Symptoms of chronic low back pain for more than six months; Absence of neurological defects; Absence of epidural injection; Absence of radicular syndrome; No respond to traditional treatments; Positive diagnostic block; Hyperextension pain; No history of lumbar surgery; Contraindication of lumbar surgery; Signing consent to participate in the study. Main exclusion criteria: Patients previously treated with radiofrequency; Coagulation disorders; Contrast sensitivity radio- opaque or local anesthetic solution; Malignancy; Psychiatric problems and poor patient cooperation; Speech problems; Pregnancy; Surgery indication; Local skin infection at the operative site; Spinal deformities; Spinal stenosis; Discogenic axial pain; Degenerative disc herniation; Epidural injection of steroids in the past six months; History of opioid abuse; Use of long -acting opioids recent Radicular pain over a year ago; Patients with a history of sensitivity to corticosteroids or contrast material; Inflammatory spondylopathy; Vertebral fracture , tumor , or infection of the spine; No signing consent to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: Before the treatment, 24 hours, 1 week, 1 month, 3 months after the treatment. Method of measurement: Visual analog scale.;Disability measurement. Timepoint: Before the treatment, 24 hours, 1 week, 1 month, 3 months after the treatment. Method of measurement: Oswestry disability index score.;Successful treatment rate. Timepoint: 3 months after the treatment. Method of measurement: Pain relief more than 50%.;Patient request for analgesia. Timepoint: Before the treatment, 24 hours, 1 week, 1 month, 3 months after the treatment. Method of measurement: Based on the patient's request.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnad Imani MD.

Rasul Hospital

farimani@tums.ac.ir+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026